Portal Hypertensive Gastropathy (Mild - Mosaic)

1. Executive Overview: What is Portal Hypertensive Gastropathy?

Portal Hypertensive Gastropathy (PHG) is a clinical condition characterized by changes in the mucosal lining of the stomach, specifically associated with portal hypertension. In the context of liver disease, the portal vein—which carries blood from the digestive organs to the liver—becomes obstructed or narrowed. This leads to increased pressure within the portal venous system.

When this pressure rises, it causes congestion in the gastric mucosa, leading to the characteristic "mosaic" or "snake-skin" appearance observed during an upper endoscopy (EGD). Mild PHG is the most common manifestation, representing a clinical finding that requires diligent monitoring rather than immediate surgical intervention. While PHG is not an ulcer, it represents a fragile state of the stomach lining that can bleed if portal pressures remain uncontrolled.

2. Pathophysiology, Etiology, and Risk Factors

The Pathophysiology of PHG

The development of PHG is directly linked to hemodynamic alterations in the gastric microcirculation. The primary mechanisms include:

• Congestive Gastropathy: Increased hydrostatic pressure in the gastric venules and capillaries leads to dilation and tortuosity.
• Vascular Endothelial Changes: Chronic portal hypertension triggers the release of vasoactive substances, such as nitric oxide and vascular endothelial growth factor (VEGF), which contribute to mucosal hyperemia.
• Reduced Protective Factors: The mucosal barrier’s ability to defend against gastric acid is compromised due to impaired blood flow and metabolic alterations.

Etiology and Risk Factors

PHG is almost exclusively a complication of portal hypertension. The most frequent underlying cause is cirrhosis of the liver.

3. Signs, Symptoms, and Clinical Presentation

Mild PHG is frequently asymptomatic. Patients often undergo an endoscopy for unrelated reasons (e.g., screening for esophageal varices) and are incidentally diagnosed with the condition. When symptoms do occur, they are often indicative of chronic, low-grade blood loss rather than acute hemorrhage.

Common Clinical Findings:

• Asymptomatic Presentation: The majority of patients with mild mosaic patterns remain symptom-free.
• Occult Gastrointestinal Bleeding: Chronic oozing may lead to iron-deficiency anemia, manifesting as fatigue, pallor, and exertional dyspnea.
• Dyspepsia: Some patients may report vague epigastric discomfort or fullness.
• Acute Hemorrhage (Rare in Mild PHG): While severe PHG can cause hematemesis (vomiting blood) or melena (black, tarry stools), this is rare in mild, mosaic-pattern cases.

4. Standard Diagnostic Evaluation & Workup

The diagnosis of PHG is primarily endoscopic. It is a clinical diagnosis based on visual inspection during a procedure.

The Gold Standard: Upper Endoscopy (EGD)

The "mosaic" or "snake-skin" pattern is the hallmark of mild PHG. During an endoscopy, the gastroenterologist will observe a fine, white, reticular network separating areas of erythematous (red) mucosa.

Diagnostic Classification (McCormack Classification)

1. Mild: Fine, pink, mosaic-like pattern.
2. Severe: Cherry-red spots or diffuse hemorrhagic gastritis.

Necessary Workup:

• Complete Blood Count (CBC): To screen for anemia or thrombocytopenia.
• Iron Studies: To assess ferritin and total iron-binding capacity.
• Liver Function Tests (LFTs): To assess the severity of the underlying hepatic disease.
• Coagulation Profile (INR/PT): Essential for assessing bleeding risk.
• Biopsy: While not always required to diagnose PHG, biopsies may be taken to rule out Helicobacter pylori infection or other forms of gastritis.

5. Therapeutic Interventions

Management of mild PHG is focused on reducing portal pressure and addressing the underlying liver disease.

Pharmacotherapy

• Non-selective Beta-Blockers (NSBBs): Medications such as Propranolol or Nadolol are the first-line treatment. They work by reducing splanchnic blood flow, thereby lowering portal pressure.
• Iron Supplementation: If the patient is anemic due to chronic occult blood loss, oral or intravenous iron therapy is indicated.
• Proton Pump Inhibitors (PPIs): While not curative for the vascular changes of PHG, they may be prescribed to protect the mucosa from acid-peptic injury.

Lifestyle and Management

• Alcohol Cessation: Mandatory for patients with alcoholic cirrhosis to prevent further hepatic insult.
• Dietary Adjustments: Low-sodium diets are often recommended to manage ascites, which is frequently comorbid with portal hypertension.
• Regular Surveillance: Patients with mild PHG should undergo periodic EGD surveillance as determined by their hepatologist.

Surgical/Interventional Options (Reserved for Severe Cases)

In cases where PHG progresses to severe hemorrhage despite medical management, interventional procedures like Transjugular Intrahepatic Portosystemic Shunt (TIPS) may be considered to decompress the portal system.

6. Frequently Asked Questions (FAQ)

1. Is "Mosaic" PHG a form of cancer?
No. PHG is a vascular condition caused by high pressure in the stomach veins. It is not cancerous.

2. Can PHG be cured completely?
PHG is a reflection of portal hypertension. If the underlying liver disease is treated or cured (e.g., via liver transplant), the PHG may resolve. Otherwise, it is managed through pressure reduction.

3. What does "Mild" mean in my diagnosis?
"Mild" indicates that the mucosal changes are limited to a mosaic pattern without signs of active bleeding or "cherry-red spots," which are signs of higher risk.

4. Do I need to change my diet?
While there is no specific "PHG diet," patients with liver disease should adhere to a low-sodium, heart-healthy diet to manage portal pressure and fluid retention.

5. How often should I have an endoscopy?
Your gastroenterologist will determine the frequency based on your liver function and the severity of your portal hypertension, typically every 1–3 years.

6. Can I take NSAIDs like Ibuprofen?
Patients with PHG should generally avoid NSAIDs, as they can irritate the stomach lining and increase the risk of bleeding. Consult your doctor for pain management alternatives.

7. Is iron-deficiency anemia common with PHG?
Yes, if the fragile stomach lining is leaking small amounts of blood over time, iron-deficiency anemia is a common complication.

8. What are the warning signs of a bleed?
Seek emergency care if you experience vomiting blood (or material that looks like coffee grounds) or pass black, tarry, or bloody stools.

9. Do beta-blockers work for everyone?
Beta-blockers are effective for many, but they are not suitable for all patients due to side effects or other medical conditions. Your doctor will tailor your regimen.

10. Is PHG the same as Esophageal Varices?
Both are caused by portal hypertension, but they occur in different locations. Varices are dilated veins in the esophagus, while PHG affects the lining of the stomach.

Disclaimer: This guide is for educational purposes and does not replace professional medical advice. Always consult with your hepatologist or gastroenterologist regarding your specific clinical findings and treatment plan.

Related Clinical Integration

In the management of mild mosaic portal hypertensive gastropathy, clinical strategy focuses on reducing portal venous pressure and performing routine endoscopic surveillance to monitor disease progression. Pharmacological intervention with Propranolol / بروبرانولول 20mg serves as the primary non-selective beta-blocker therapy to decrease splanchnic blood flow and mitigate the risk of hemorrhage associated with gastric mucosal congestion. Concurrently, periodic diagnostic and therapeutic assessment is facilitated using the Gastroscope (GIF-1TQ260 - Therapeutic) / منظار المعدة (GIF-1TQ260 - علاجي), which allows clinicians to visualize the characteristic mosaic pattern of the gastric mucosa and perform necessary interventions should the condition advance or complications arise.